Farideh Afshin Javid

Title: Farideh Afshin Javid: Innovator in Phytocannabinoid Research

Introduction

Farideh Afshin Javid is a notable inventor based in Huddersfield, GB. She has made significant contributions to the field of medical research, particularly in the treatment of ovarian cancer. Her innovative approach utilizes phytocannabinoids, which are compounds derived from the cannabis plant, to develop potential therapies for this challenging disease.

Latest Patents

Farideh holds a patent for the "Use of phytocannabinoids in the treatment of ovarian carcinoma." This invention focuses on the application of various phytocannabinoids, including cannabidiol (CBD), cannabidiol acid (CBDA), cannabigerol (CBG), cannabigerolic acid (CBGA), cannabigerol propyl variant (CBGV), and tetrahydrocannabivarin (THCV). The patent emphasizes the potential of these compounds, particularly in combination, to enhance treatment efficacy for ovarian cancer.

Career Highlights

Throughout her career, Farideh has demonstrated a commitment to advancing medical science through her research. Her work has not only contributed to the understanding of phytocannabinoids but also opened new avenues for cancer treatment. With a patent portfolio that includes 1 patent, she continues to be a driving force in her field.

Collaborations

Farideh has collaborated with esteemed colleagues, including Marnie Duncan and Colin Stott. These partnerships have enriched her research and expanded the impact of her innovations in the medical community.

Conclusion

Farideh Afshin Javid is a pioneering inventor whose work in phytocannabinoid research holds promise for the treatment of ovarian cancer. Her contributions are paving the way for future advancements in medical therapies.